Trump considers fast-tracking UK COVID-19 vaccine before US election

Financial Times

24 August 2020 - Move comes as FDA gives emergency authorisation for use of plasma from recovered patients.

The Trump administration is considering bypassing normal US regulatory standards to fast-track an experimental coronavirus vaccine from the UK for use in America ahead of the presidential election, according to three people briefed on the plan.

One option being explored to speed up the availability of a vaccine would involve the US FDA awarding “emergency use authorisation” in October to a vaccine being developed in a partnership between AstraZeneca and Oxford university, based on the results from a relatively small UK study if it is successful, the people said.

Read Financial Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Vaccine , Fast track , COVID-19